Skip to content

Core facility template

Core facility News

  • What actually is the Emma Center for Personalized Medicine?
    What actually is the Emma Center for Personalized Medicine? At the Emma Center for Personalized Medicine (Emma CPM), they accelerate the development, application, and evaluation of therapies for individuals with rare genetic diseases through a tailored approach.
  • Amsterdam Neuroscience Annual Meeting 2026: The future of cognition - Technology and the human brain
    Amsterdam Neuroscience Annual Meeting 2026: The future of cognition - Technology and the human brain The Amsterdam Neuroscience Annual Meeting 2026 will take place on January 16, with this year's theme: The Future of Cognition - Technology and the Human Brain. As a member of the Amsterdam Neuroscience community, you are invited to be part of an inspiring day and to share ideas, get an update on neuroscience research, explore new collaborations, and shape the future of neuroscience.
  • Five Amsterdam Neuroscience researchers awarded Vidi Grant
    Five Amsterdam Neuroscience researchers awarded Vidi Grant Five talented researchers from Amsterdam Neuroscience have been awarded a Vidi grant from the Dutch Research Council (NWO). Congratulations to Elsmarieke van der Giessen, Elseline Hoekzema, Max Koppers, Anouk Schrantee and Jorien Treur. NWO has granted a maximum of 850.000 euros to the researchers.

Subscribe to our Newsletter

Sign up
Archive
Subscribe to our Newsletter

All news from Core facility

Hersenstichting grant for Femke Lamers & Yuri Milaneschi
Worldwide guideline on the use of MRI in multiple sclerosis
Abstract submissions annual ACS conference now open!
Improving healthcare by listening to our patients
Charting a course towards precision treatment for colorectal cancer patients
Summer lecture with developers of mRNA corona vaccine
Fulbright Grant for Eva van der Linden
ZonMw grant for Karin Gerrits
IkHerstel app wins the ‘VGZ Zinnige Zorg Award 2021’
Promising Phase III data for a new passive vaccine against RSV
Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes
The new APH Quality Handbook is live!
Opening of a new @ease location at Uilenstede
The Biosciences and Society Foundation has published the book 'Lyme Disease, about ticks, tick bites and tick-bite diseases".
Developing new medicines for patients with multiple myeloma
Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination.
Lockdown prevents many serious bacterial infections
Pro-resolving lipid mediator Lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome.
Getting the corona vaccine: ‘No thank you!’.
First edition of APH Junified 2021
Potential risks of induced labor in uncomplicated term pregnancies
Green light for Alzheimer's medicine Aducanumab in the USA
IkHerstel app wins the ‘VGZ Zinnige Zorg Award 2021’
AMS Investment grant for Wendy Scholten-Peeters
AMS Investment Grant for Aart Nederveen
Femke Lamers new progam leader Mental Health
Older adults report cancellation of care during the pandemic
Recordings of TN2 Webinars
Postdoc position available at the Verhaak laboratory at the Jackson Laboratory for Genomic Medicine